Paul Tudor Jones's RVMD Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 92,391 shares of Revolution Medicines, Inc. (RVMD) worth $7.36 M, representing 0.01% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in RVMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 92,391 shares. Largest reduction occurred in Q3 2021, reducing 75,797 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Revolution Medicines (RVMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Revolution Medicines (RVMD) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +92,391 | New Buy | 92,391 | $79.65 |
| Q3 2025 | -35,185 | Sold Out | 0 | $0.00 |
| Q2 2025 | +35,185 | New Buy | 35,185 | $36.79 |
| Q4 2024 | -38,306 | Sold Out | 0 | $0.00 |
| Q3 2024 | +38,306 | New Buy | 38,306 | $45.35 |
| Q3 2023 | -13,583 | Sold Out | 0 | $0.00 |
| Q2 2023 | +69 | Add 0.51% | 13,583 | $26.75 |
| Q1 2023 | +4,075 | Add 43.17% | 13,514 | $0.02 |
| Q4 2022 | +9,439 | New Buy | 9,439 | $0.02 |
| Q3 2022 | -22,998 | Sold Out | 0 | $0.00 |
| Q2 2022 | -44,723 | Reduce 66.04% | 22,998 | $19.48 |
| Q1 2022 | +67,721 | New Buy | 67,721 | $25.52 |
| Q3 2021 | -75,797 | Sold Out | 0 | $0.00 |
| Q2 2021 | +75,797 | New Buy | 75,797 | $31.74 |
Paul Tudor Jones's Revolution Medicines Investment FAQs
Paul Tudor Jones first purchased Revolution Medicines, Inc. (RVMD) in Q2 2021, acquiring 75,797 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Revolution Medicines, Inc. (RVMD) for 14 quarters since Q2 2021.
Paul Tudor Jones's largest addition to Revolution Medicines, Inc. (RVMD) was in Q4 2025, adding 92,391 shares worth $7.36 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 92,391 shares of Revolution Medicines, Inc. (RVMD), valued at approximately $7.36 M.
As of the Q4 2025 filing, Revolution Medicines, Inc. (RVMD) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Revolution Medicines, Inc. (RVMD) was 92,391 shares, as reported at the end of Q4 2025.